The latest price of Jisandai (Bingtongsha) in 2024

Epclusa is a drug used to treat chronic hepatitis C. It is a direct antiviral drug that acts directly on the virus. Hepatitis C is a viral infection caused by the hepatitis C virus (HCV). It can cause liver inflammation and damage, which may lead to serious complications such as cirrhosis and liver cancer.

Jisandai (Bingtonsha) has been launched in China and has been included in medical insurance. Patients can buy it domestically. The domestic price is about two to three thousand yuan. For specific prices and medical insurance reimbursement policies, please consult the local hospital pharmacy. The cheaper ones abroad are the generic drugs of Jisandai (Bingtonsa), mainly Bangladeshi and Indian versions, with prices ranging from a few hundred yuan to more than a thousand yuan, and the ingredients are basically the same as the domestic original drugs.

Jisandai (Bingtonsa) is a prescription drug manufactured by an American pharmaceutical company. It was approved for marketing by the U.S. Food and Drug Administration (FDA) in in 2016. It is a combination drug containing two active ingredients: Sofosbuvir and Velpatasvir. These two components act on HCV through different mechanisms and jointly inhibit viral replication, thereby reducing the amount of virus in the body and ultimately achieving the purpose of treatment.

Compared with traditional hepatitis C treatment options, Jisanda (Bingtonsa) has many advantages. First, it is an oral medication that patients can take at home without the need for hospitalization or regular trips to the hospital. Secondly, Jisandai (Bingtonsha) is a fully oral course of treatment that usually only needs to be taken continuously for 8 to 12 weeks, which greatly shortens the treatment time compared with the traditional treatment plan of 24 to 48 weeks. In addition, the efficacy of GISADA (Bingtonsa) is also higher. Clinical trials show that most patients who receive GISADA (Bingtonsa) can achieve viral elimination, that is, the hepatitis C virusRNA cannot be detected after the end of treatment, which brings better treatment results and quality of life to patients.

AlthoughJi Sandai (Bingtongsha)Has many advantages, but it may also cause some side effects. Common side effects include headache, fatigue, nausea, diarrhea and other digestive problems, as well as abnormal liver function. Therefore, when using GISANDA (Bingtonsa) to treat hepatitis C, doctors usually monitor the patient's liver function and drug tolerance, and adjust the treatment plan as needed.